Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer mortality worldwide. Various imaging modalities provide important information about HCC for its clinical management. Since positron-emission tomography (PET) or PET-computed tomography was introduced to the oncologic setting, it h...
Gespeichert in:
| Veröffentlicht in: | World journal of gastroenterology : WJG 2019-08, Vol.25 (32), p.4682-4695 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 4695 |
|---|---|
| container_issue | 32 |
| container_start_page | 4682 |
| container_title | World journal of gastroenterology : WJG |
| container_volume | 25 |
| creator | Lu, Ren-Cai She, Bo Gao, Wen-Tao Ji, Yun-Hai Xu, Dong-Dong Wang, Quan-Shi Wang, Shao-Bo |
| description | Hepatocellular carcinoma (HCC) is one of the leading causes of cancer mortality worldwide. Various imaging modalities provide important information about HCC for its clinical management. Since positron-emission tomography (PET) or PET-computed tomography was introduced to the oncologic setting, it has played crucial roles in detecting, distinguishing, accurately staging, and evaluating local, residual, and recurrent HCC. PET imaging visualizes tissue metabolic information that is closely associated with treatment. Dynamic PET imaging and dual-tracer have emerged as complementary techniques that aid in various aspects of HCC diagnosis. The advent of new radiotracers and the development of immuno-PET and PET-magnetic resonance imaging have improved the ability to detect lesions and have made great progress in treatment surveillance. The current PET diagnostic capabilities for HCC and the supplementary techniques are reviewed herein. |
| doi_str_mv | 10.3748/wjg.v25.i32.4682 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6718031</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2293026020</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-1fc17056aa45ad1689a26fd9b9826dcdbd1c437a27fd9f6d279c1a31d9b429693</originalsourceid><addsrcrecordid>eNpVkT1v2zAQhomgQeI62TsVHLvIJY8SJXYoUBhJWiBAMqRriTNF2TIkUSUpB_73oWHXaKYD7t577-Mh5BNnC1Hm1dfX7Xqxg2LRCljksoILMgPgKoMqZx_IjDNWZkpAeU0-hrBlDIQo4IpcC15AxVQ-I3-eXWijd0Nm-zaE1g00ut6tPY6bPW2cpxs7YnTGdt3UoacGvWkH1-M3upy8t0OkIWKcAsWhps0UJ2_p6F0YrYnhhlw22AV7e4pz8vv-7mX5M3t8evi1_PGYmVxCzHhjeMkKiZgXWHNZKQTZ1GqlKpC1qVc1N7koEcqUbGQNpTIcBU-KHJRUYk6-H33HadXb2qS1PHZ69G2Pfq8dtvp9ZWg3eu12Wpa8YoIngy8nA-_-TjZEnd5xOBoH66agAZRgIBmwJGVHqUlXBm-b8xjO9AGLTlh0wqITFn3Aklo-_7_eueEfB_EGtRmN1g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2293026020</pqid></control><display><type>article</type><title>Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects</title><source>MEDLINE</source><source>Baishideng "World Journal of" online journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Lu, Ren-Cai ; She, Bo ; Gao, Wen-Tao ; Ji, Yun-Hai ; Xu, Dong-Dong ; Wang, Quan-Shi ; Wang, Shao-Bo</creator><creatorcontrib>Lu, Ren-Cai ; She, Bo ; Gao, Wen-Tao ; Ji, Yun-Hai ; Xu, Dong-Dong ; Wang, Quan-Shi ; Wang, Shao-Bo</creatorcontrib><description>Hepatocellular carcinoma (HCC) is one of the leading causes of cancer mortality worldwide. Various imaging modalities provide important information about HCC for its clinical management. Since positron-emission tomography (PET) or PET-computed tomography was introduced to the oncologic setting, it has played crucial roles in detecting, distinguishing, accurately staging, and evaluating local, residual, and recurrent HCC. PET imaging visualizes tissue metabolic information that is closely associated with treatment. Dynamic PET imaging and dual-tracer have emerged as complementary techniques that aid in various aspects of HCC diagnosis. The advent of new radiotracers and the development of immuno-PET and PET-magnetic resonance imaging have improved the ability to detect lesions and have made great progress in treatment surveillance. The current PET diagnostic capabilities for HCC and the supplementary techniques are reviewed herein.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v25.i32.4682</identifier><identifier>PMID: 31528094</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>Carcinoma, Hepatocellular - diagnostic imaging ; Carcinoma, Hepatocellular - mortality ; Carcinoma, Hepatocellular - pathology ; Diagnosis, Differential ; Humans ; Immunoconjugates - administration & dosage ; Liver Neoplasms - diagnostic imaging ; Liver Neoplasms - mortality ; Liver Neoplasms - pathology ; Magnetic Resonance Imaging - methods ; Magnetic Resonance Imaging - trends ; Minireviews ; Neoplasm Staging ; Positron Emission Tomography Computed Tomography - methods ; Positron Emission Tomography Computed Tomography - trends ; Prognosis ; Radiopharmaceuticals - administration & dosage</subject><ispartof>World journal of gastroenterology : WJG, 2019-08, Vol.25 (32), p.4682-4695</ispartof><rights>The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. 2019</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-1fc17056aa45ad1689a26fd9b9826dcdbd1c437a27fd9f6d279c1a31d9b429693</citedby><cites>FETCH-LOGICAL-c462t-1fc17056aa45ad1689a26fd9b9826dcdbd1c437a27fd9f6d279c1a31d9b429693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718031/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718031/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31528094$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lu, Ren-Cai</creatorcontrib><creatorcontrib>She, Bo</creatorcontrib><creatorcontrib>Gao, Wen-Tao</creatorcontrib><creatorcontrib>Ji, Yun-Hai</creatorcontrib><creatorcontrib>Xu, Dong-Dong</creatorcontrib><creatorcontrib>Wang, Quan-Shi</creatorcontrib><creatorcontrib>Wang, Shao-Bo</creatorcontrib><title>Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects</title><title>World journal of gastroenterology : WJG</title><addtitle>World J Gastroenterol</addtitle><description>Hepatocellular carcinoma (HCC) is one of the leading causes of cancer mortality worldwide. Various imaging modalities provide important information about HCC for its clinical management. Since positron-emission tomography (PET) or PET-computed tomography was introduced to the oncologic setting, it has played crucial roles in detecting, distinguishing, accurately staging, and evaluating local, residual, and recurrent HCC. PET imaging visualizes tissue metabolic information that is closely associated with treatment. Dynamic PET imaging and dual-tracer have emerged as complementary techniques that aid in various aspects of HCC diagnosis. The advent of new radiotracers and the development of immuno-PET and PET-magnetic resonance imaging have improved the ability to detect lesions and have made great progress in treatment surveillance. The current PET diagnostic capabilities for HCC and the supplementary techniques are reviewed herein.</description><subject>Carcinoma, Hepatocellular - diagnostic imaging</subject><subject>Carcinoma, Hepatocellular - mortality</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Diagnosis, Differential</subject><subject>Humans</subject><subject>Immunoconjugates - administration & dosage</subject><subject>Liver Neoplasms - diagnostic imaging</subject><subject>Liver Neoplasms - mortality</subject><subject>Liver Neoplasms - pathology</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Magnetic Resonance Imaging - trends</subject><subject>Minireviews</subject><subject>Neoplasm Staging</subject><subject>Positron Emission Tomography Computed Tomography - methods</subject><subject>Positron Emission Tomography Computed Tomography - trends</subject><subject>Prognosis</subject><subject>Radiopharmaceuticals - administration & dosage</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkT1v2zAQhomgQeI62TsVHLvIJY8SJXYoUBhJWiBAMqRriTNF2TIkUSUpB_73oWHXaKYD7t577-Mh5BNnC1Hm1dfX7Xqxg2LRCljksoILMgPgKoMqZx_IjDNWZkpAeU0-hrBlDIQo4IpcC15AxVQ-I3-eXWijd0Nm-zaE1g00ut6tPY6bPW2cpxs7YnTGdt3UoacGvWkH1-M3upy8t0OkIWKcAsWhps0UJ2_p6F0YrYnhhlw22AV7e4pz8vv-7mX5M3t8evi1_PGYmVxCzHhjeMkKiZgXWHNZKQTZ1GqlKpC1qVc1N7koEcqUbGQNpTIcBU-KHJRUYk6-H33HadXb2qS1PHZ69G2Pfq8dtvp9ZWg3eu12Wpa8YoIngy8nA-_-TjZEnd5xOBoH66agAZRgIBmwJGVHqUlXBm-b8xjO9AGLTlh0wqITFn3Aklo-_7_eueEfB_EGtRmN1g</recordid><startdate>20190828</startdate><enddate>20190828</enddate><creator>Lu, Ren-Cai</creator><creator>She, Bo</creator><creator>Gao, Wen-Tao</creator><creator>Ji, Yun-Hai</creator><creator>Xu, Dong-Dong</creator><creator>Wang, Quan-Shi</creator><creator>Wang, Shao-Bo</creator><general>Baishideng Publishing Group Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190828</creationdate><title>Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects</title><author>Lu, Ren-Cai ; She, Bo ; Gao, Wen-Tao ; Ji, Yun-Hai ; Xu, Dong-Dong ; Wang, Quan-Shi ; Wang, Shao-Bo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-1fc17056aa45ad1689a26fd9b9826dcdbd1c437a27fd9f6d279c1a31d9b429693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Carcinoma, Hepatocellular - diagnostic imaging</topic><topic>Carcinoma, Hepatocellular - mortality</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Diagnosis, Differential</topic><topic>Humans</topic><topic>Immunoconjugates - administration & dosage</topic><topic>Liver Neoplasms - diagnostic imaging</topic><topic>Liver Neoplasms - mortality</topic><topic>Liver Neoplasms - pathology</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Magnetic Resonance Imaging - trends</topic><topic>Minireviews</topic><topic>Neoplasm Staging</topic><topic>Positron Emission Tomography Computed Tomography - methods</topic><topic>Positron Emission Tomography Computed Tomography - trends</topic><topic>Prognosis</topic><topic>Radiopharmaceuticals - administration & dosage</topic><toplevel>online_resources</toplevel><creatorcontrib>Lu, Ren-Cai</creatorcontrib><creatorcontrib>She, Bo</creatorcontrib><creatorcontrib>Gao, Wen-Tao</creatorcontrib><creatorcontrib>Ji, Yun-Hai</creatorcontrib><creatorcontrib>Xu, Dong-Dong</creatorcontrib><creatorcontrib>Wang, Quan-Shi</creatorcontrib><creatorcontrib>Wang, Shao-Bo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lu, Ren-Cai</au><au>She, Bo</au><au>Gao, Wen-Tao</au><au>Ji, Yun-Hai</au><au>Xu, Dong-Dong</au><au>Wang, Quan-Shi</au><au>Wang, Shao-Bo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World J Gastroenterol</addtitle><date>2019-08-28</date><risdate>2019</risdate><volume>25</volume><issue>32</issue><spage>4682</spage><epage>4695</epage><pages>4682-4695</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>Hepatocellular carcinoma (HCC) is one of the leading causes of cancer mortality worldwide. Various imaging modalities provide important information about HCC for its clinical management. Since positron-emission tomography (PET) or PET-computed tomography was introduced to the oncologic setting, it has played crucial roles in detecting, distinguishing, accurately staging, and evaluating local, residual, and recurrent HCC. PET imaging visualizes tissue metabolic information that is closely associated with treatment. Dynamic PET imaging and dual-tracer have emerged as complementary techniques that aid in various aspects of HCC diagnosis. The advent of new radiotracers and the development of immuno-PET and PET-magnetic resonance imaging have improved the ability to detect lesions and have made great progress in treatment surveillance. The current PET diagnostic capabilities for HCC and the supplementary techniques are reviewed herein.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>31528094</pmid><doi>10.3748/wjg.v25.i32.4682</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1007-9327 |
| ispartof | World journal of gastroenterology : WJG, 2019-08, Vol.25 (32), p.4682-4695 |
| issn | 1007-9327 2219-2840 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6718031 |
| source | MEDLINE; Baishideng "World Journal of" online journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
| subjects | Carcinoma, Hepatocellular - diagnostic imaging Carcinoma, Hepatocellular - mortality Carcinoma, Hepatocellular - pathology Diagnosis, Differential Humans Immunoconjugates - administration & dosage Liver Neoplasms - diagnostic imaging Liver Neoplasms - mortality Liver Neoplasms - pathology Magnetic Resonance Imaging - methods Magnetic Resonance Imaging - trends Minireviews Neoplasm Staging Positron Emission Tomography Computed Tomography - methods Positron Emission Tomography Computed Tomography - trends Prognosis Radiopharmaceuticals - administration & dosage |
| title | Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T02%3A09%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Positron-emission%20tomography%20for%20hepatocellular%20carcinoma:%20Current%20status%20and%20future%20prospects&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Lu,%20Ren-Cai&rft.date=2019-08-28&rft.volume=25&rft.issue=32&rft.spage=4682&rft.epage=4695&rft.pages=4682-4695&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v25.i32.4682&rft_dat=%3Cproquest_pubme%3E2293026020%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2293026020&rft_id=info:pmid/31528094&rfr_iscdi=true |